- Featured Product
- KD/KO Validated
LIMD2 Polyclonal antibody
LIMD2 Polyclonal Antibody for WB, IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IF, IHC, ELISA
Conjugate
Unconjugated
Cat no : 15471-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | U-937 cells, Raji cells |
Positive IHC detected in | human liver cancer tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 1 publications below |
WB | See 1 publications below |
IF | See 1 publications below |
Product Information
15471-1-AP targets LIMD2 in WB, IF, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | LIMD2 fusion protein Ag7775 相同性解析による交差性が予測される生物種 |
Full Name | LIM domain containing 2 |
Calculated molecular weight | 14 kDa |
Observed molecular weight | 16-20 kDa |
GenBank accession number | BC004400 |
Gene symbol | LIMD2 |
Gene ID (NCBI) | 80774 |
RRID | AB_10859817 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Protocols
Product Specific Protocols | |
---|---|
WB protocol for LIMD2 antibody 15471-1-AP | Download protocol |
IHC protocol for LIMD2 antibody 15471-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Bioengineered LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway. | ||
Mol Biol Rep Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway
|